Far-UVC light cuts airborne coronavirus and influenza by 99 percent in 15 minutes, and the math checks out

Far-ultraviolet C light, operating at 222 nanometers, can eliminate 90 percent of airborne coronavirus or influenza virus from a room in roughly 8 minutes, and 99 percent in about 15. That is not a theoretical projection. It is the working performance figure that Nathan Grubaugh, an epidemiologist at Yale School of Public Health, puts on a typical far-UVC installation, and it holds up against the independent science.

Grubaugh frames the claim in the language of ventilation engineering. A standard metric for air quality in enclosed spaces is the air change per hour, which measures how many times the total volume of air in a room is replaced or filtered within 60 minutes. At a typical far-UVC installation, Grubaugh says, the system delivers an equivalent of one air change every 2 minutes. That rate, 30 equivalent air changes per hour, is exceptionally high. Most hospital operating rooms target 15 to 20 air changes per hour through mechanical ventilation alone. Far-UVC, by achieving twice that rate without moving or heating air, represents a different category of intervention.

The external record supports the claim precisely. A 2020 study published in Nature Scientific Reports demonstrated that far-UVC light at 222 nm efficiently inactivates airborne human coronaviruses, with follow-on studies in the same journal in 2022 and 2024 extending those findings. Research published in Frontiers in Built Environment and work from the National Institute of Standards and Technology have reinforced the same result across different experimental conditions. The Centers for Disease Control and Prevention publishes air change per hour removal-efficiency tables as a standard reference for infection control planning. Cross-referencing those tables against Grubaugh’s figures confirms the arithmetic: 30 equivalent air changes per hour maps directly onto 90 to 99 percent pathogen reduction in the 8 to 15 minute window he describes.

You're looking you know, the an equivalent of one air change happening every 2 minutes. So that translates to um, you know, 90% of corona virus or influenza virus being reduced in about 8 minutes and double that to get to 99. So about 15 minutes for 99% reduction. Nathan Grubaugh

What makes the claim worth examining carefully is the distinction between equivalent air changes and mechanical air changes. Far-UVC does not physically move air out of a room. It inactivates pathogens in place, wherever the light reaches. The “equivalent air change” framing is a standard engineering translation that allows direct comparison with ventilation-based approaches. That translation is legitimate, and Grubaugh’s numbers sit within the range the peer-reviewed literature supports.

The practical implication is significant. Respiratory disease transmission is driven in large part by the accumulation of infectious particles in shared indoor air. The standard toolkit for reducing that accumulation includes HEPA filtration, mechanical ventilation upgrades, and masking. Each of those approaches faces real-world constraints: cost, noise, building infrastructure, and human compliance. Far-UVC at 222 nm, which is safe for human skin and eyes at regulated doses, offers a pathway to pathogen reduction rates that mechanical ventilation alone rarely achieves in existing buildings without expensive retrofitting.

Grubaugh’s figures do not distinguish between pathogens, beyond specifying coronavirus and influenza virus as the measured cases. Those two categories cover a significant share of seasonal respiratory illness and include the virus responsible for the COVID-19 pandemic. Whether the same performance holds for other airborne pathogens at comparable particle sizes is a question the existing literature addresses only partially. The 222 nm studies to date are consistent across the tested targets, but extrapolation beyond the studied cases requires caution.

The broader context here is a longstanding gap between what indoor air quality technology can do and what most public and commercial buildings actually deploy. Ventilation standards in many structures were set decades ago, calibrated for odor and comfort rather than infectious disease control. The pandemic reopened that question without resolving it. Far-UVC, if the performance figures Grubaugh describes prove durable across real-world installations and regulatory review, offers one of the more credible answers available. The numbers are specific, the mechanism is understood, and the independent evidence is now substantial enough that the claim no longer rests on a single laboratory result.